
Amicus Therapeutics, ProShares UltraPro Short QQQ, and Solstice Advanced Mat are the three Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid-cap stocks are shares of companies with medium-sized market capitalizations—typically roughly $2 billion to $10 billion, though exact cutoffs vary by index provider. They generally offer a balance between the growth potential and higher volatility of small-cap stocks and the greater stability but slower growth of large-cap stocks, appealing to investors seeking a mix of growth and risk. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.
Amicus Therapeutics (FOLD)
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
Read Our Latest Research Report on SQQQ
Solstice Advanced Mat (SOLS)
Solstice Advanced Materials is a leading global specialty materials company that advances science for smarter outcomes. Solstice offers high-performance solutions that enable critical industries and applications, including refrigerants, semiconductor manufacturing, data center cooling, nuclear power, protective fibers, healthcare packaging and more.
Read Our Latest Research Report on SOLS
Featured Stories
- MarketBeat’s Top Five Stocks to Own in December 2025
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
- MarketBeat Week in Review – 12/15 – 12/19
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
